Literature DB >> 22359291

The epigenetics of brain tumors.

Adrian M Dubuc1, Stephen Mack, Alexander Unterberger, Paul A Northcott, Michael D Taylor.   

Abstract

Glioblastoma, medulloblastoma, and ependymoma represent molecularly and clinically diverse forms of adult and pediatric brain tumors. While each tumor displays genetic, transcriptional, and cytogenetic heterogeneity, the epigenome of these tumors has only recently emerged as a major field of interest. Here, we describe advances in our understanding of the epigenetics of brain tumors, focusing on DNA methylation, histone modifications, and microRNA deregulation which contribute to the pathogenesis of these diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22359291     DOI: 10.1007/978-1-61779-612-8_8

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

Review 1.  Metabolic modulation of epigenetics in gliomas.

Authors:  Sriram Venneti; Craig B Thompson
Journal:  Brain Pathol       Date:  2013-03       Impact factor: 6.508

Review 2.  Posterior fossa ependymoma: current insights.

Authors:  Yuan Y Thompson; Vijay Ramaswamy; Phedias Diamandis; Craig Daniels; Michael D Taylor
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

3.  Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.

Authors:  BaoHan T Vo; Chunliang Li; Marc A Morgan; Ilan Theurillat; David Finkelstein; Shaela Wright; Judith Hyle; Stephanie M C Smith; Yiping Fan; Yong-Dong Wang; Gang Wu; Brent A Orr; Paul A Northcott; Ali Shilatifard; Charles J Sherr; Martine F Roussel
Journal:  Cell Rep       Date:  2017-03-21       Impact factor: 9.423

4.  Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas.

Authors:  Sriram Venneti; Michelle Madden Felicella; Thomas Coyne; Joanna J Phillips; Daniel Gorovets; Jason T Huse; Julia Kofler; Chao Lu; Tarik Tihan; Lisa M Sullivan; Mariarita Santi; Alexander R Judkins; Arie Perry; Craig B Thompson
Journal:  J Neuropathol Exp Neurol       Date:  2013-04       Impact factor: 3.685

5.  Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.

Authors:  Omar Dzaye; Feng Hu; Katja Derkow; Verena Haage; Philipp Euskirchen; Christoph Harms; Seija Lehnardt; Michael Synowitz; Susanne A Wolf; Helmut Kettenmann
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-30       Impact factor: 3.685

Review 6.  Deregulated proliferation and differentiation in brain tumors.

Authors:  Fredrik J Swartling; Matko Čančer; Aaron Frantz; Holger Weishaupt; Anders I Persson
Journal:  Cell Tissue Res       Date:  2014-11-23       Impact factor: 5.249

7.  Is glioblastoma an epigenetic malignancy?

Authors:  Marta Maleszewska; Bozena Kaminska
Journal:  Cancers (Basel)       Date:  2013-09-03       Impact factor: 6.639

8.  Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma.

Authors:  Samrat Roy Choudhury; Yi Cui; Jacob R Milton; Jian Li; Joseph Irudayaraj
Journal:  Clin Epigenetics       Date:  2015-10-07       Impact factor: 6.551

9.  Polycomb group gene BMI1 controls invasion of medulloblastoma cells and inhibits BMP-regulated cell adhesion.

Authors:  Ashirwad Merve; Adrian M Dubuc; Xinyu Zhang; Marc Remke; Patricia A Baxter; Xiao-Nan Li; Michael D Taylor; Silvia Marino
Journal:  Acta Neuropathol Commun       Date:  2014-01-24       Impact factor: 7.801

10.  Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.

Authors:  G Fiaschetti; L Abela; N Nonoguchi; A M Dubuc; M Remke; A Boro; E Grunder; U Siler; H Ohgaki; M D Taylor; M Baumgartner; T Shalaby; M A Grotzer
Journal:  Br J Cancer       Date:  2013-12-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.